Yahoo
    Shenzhen - Delayed Quote CNY

    Jafron Biomedical Co.,Ltd. (300529.SZ)

    17.69 +0.29 (+1.67%)
    At close: October 30 at 3:04:19 PM GMT+8
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 300529.SZ
    • Previous Close 17.40
    • Open 17.15
    • Bid 17.68 x --
    • Ask 17.69 x --
    • Day's Range 17.11 - 17.79
    • 52 Week Range 14.60 - 21.38
    • Volume 16,705,040
    • Avg. Volume 7,124,469
    • Market Cap (intraday) 14.127B
    • Beta (5Y Monthly) 0.38
    • PE Ratio (TTM) 21.06
    • EPS (TTM) 0.84
    • Earnings Date --
    • Forward Dividend & Yield 0.52 (2.94%)
    • Ex-Dividend Date Jun 1, 2026
    • 1y Target Est 24.11

    Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.

    www.jafroninternational.com

    2,301

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Medical Devices

    Industry

    More about Jafron Biomedical Co.,Ltd.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

    YTD Return

    300529.SZ
    7.42%
    SSE Composite Index (000001.SS)
    9.32%

    1-Year Return

    300529.SZ
    10.07%
    SSE Composite Index (000001.SS)
    9.73%

    3-Year Return

    300529.SZ
    20.42%
    SSE Composite Index (000001.SS)
    19.11%

    5-Year Return

    300529.SZ
    61.29%
    SSE Composite Index (000001.SS)
    1.46%

    Earnings Trends

    View More

    Earnings Per Share (Normalized)

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q1 FY25
    Revenue 547.84M
    Earnings --
    Profit Margin 0.00%

    Q3

    FY23

    Q3

    FY24

    Q4

    FY24

    Q1

    FY25

    0
    200M
    400M
    600M
    0.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    24.00
    24.11 Average
    17.69 Current
    24.23 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      31.66%

    • Return on Assets (ttm)

      9.34%

    • Return on Equity (ttm)

      18.53%

    • Revenue (ttm)

      2.07B

    • Net Income Avi to Common (ttm)

      654.24M

    • Diluted EPS (ttm)

      0.84

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      2.84B

    • Total Debt/Equity (mrq)

      35.59%

    • Levered Free Cash Flow (ttm)

      396.48M

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    000661.SZ Changchun High-Tech Industry (Group) Co., Ltd.
    69.69 -2.30%
    300595.SZ Autek China Inc.
    10.29 +0.88%
    300003.SZ Lepu Medical Technology (Beijing) Co., Ltd.
    12.05 +0.67%
    300760.SZ Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    181.75 +1.54%
    002821.SZ Asymchem Laboratories (Tianjin) Co., Ltd.
    134.61 +0.30%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: